The nation of Zimbabwe has declined a substantial American healthcare agreement worth $367m (272 million pounds) spanning five years because of the United States' insistence on sensitive information.
This move became public after a official document dated December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".
A government spokesman has since explained that the United States was seeking genetic material for research and commercial gain but was not willing to guarantee the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged more talks to reach a deal acceptable to all parties so the country's critical HIV programme can be sustained.
Broader Implications
Zimbabwe's decision follows a comparable case in Kenya, where a high court halted a similar health funding agreement after concerns were filed about the security of citizens' medical information.
After resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump argued its expenditure was "inefficient" and his government was seeking direct bilateral deals to boost transparency and accountability.
As per reports, 16 nations in Africa have so far signed these new agreements, constituting more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration would have delivered extraordinary benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data for a long time, without any corresponding assurance of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," his statement read.
"Effectively, our nation would provide the raw materials for medical research with no certainty that the end products would be accessible to our population if a new disease outbreak arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its pursuit of bilateral deals were undermining systems previously established via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with future pandemics.
"This framework is intended to ensure that when a nation provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to continued dialogue with our US partners on how subsequent collaboration could be designed in a manner that honours the sovereignty and dignity of both nations."
Health Experts Reaction
Medical experts expressed it acknowledged the government's concerns, but urged that negotiations should continue since a large portion of the country's Aids initiatives were funded by external financing.
"Where technical issues arise, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.
This impasse underscores the continuing debate between accepting much-needed international aid and safeguarding a country's data in an increasingly data-driven world.